Compounds > 1-methyl-3-isobutylxanthine
Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Intestinal Neoplasms

1-methyl-3-isobutylxanthine has been researched along with Intestinal Neoplasms in 2 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Intestinal Neoplasms: Tumors or cancer of the INTESTINES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drucker, DJ2
Jin, T1
Asa, SL1
Young, TA1
Brubaker, PL1
Gajic, D1

Other Studies

2 other studies available for 1-methyl-3-isobutylxanthine and Intestinal Neoplasms

ArticleYear
Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line.
    Molecular endocrinology (Baltimore, Md.), 1994, Volume: 8, Issue:12

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Antigens, Polyomavirus Transforming; Bucladesine; Cholera Toxi

1994
Multiple cis-acting domains mediate basal and adenosine 3',5'-monophosphate-dependent glucagon gene transcription in a mouse neuroendocrine cell line.
    Endocrinology, 1993, Volume: 132, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Base Sequence; Cell Line; Chloramphenicol O-Acetyltransferase;

1993